First COVID-19 vaccine human trial finds it is safe, induces immune response

In the trial, carried out in 108 healthy adults, the vaccine demonstrated promising results after 28 days, with the final results to be evaluated in six months, the study said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news